Inventor · disambiguated record
Jamie Campbell
Also filed as: CAMPBELL JAMIE · CAMPBELL JAMIE IAIN
23 granted patents·15 pending applications·429 citations·filing 2009–2025
97Inventor score
Top patents by PatentIndex Score
38 records- 0198US9234043B1Anti-human OX40L antibodiesKYMAB LTD·Filed 2015·Granted Jan 12, 2016·21 cites·20 claims
- 0298US9139653B1Anti-human OX40L antibodies and methods of treatmentKYMAB LTD·Filed 2015·Granted Sep 22, 2015·38 cites·27 claims
- 0397US9617338B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Apr 11, 2017·78 cites·20 claims
- 0497US9567399B1Antibodies and immunocytokinesKYMAB LTD·Filed 2016·Granted Feb 14, 2017·96 cites·21 claims
- 0597US9512229B2Synergistic combinations of OX40L antibodies for the treatment of GVHDKYMAB LTD·Filed 2016·Granted Dec 6, 2016·12 cites·30 claims
- 0696US10604576B2Antibodies and immunocytokinesKYMAB LTD·Filed 2017·Granted Mar 31, 2020·25 cites·14 claims
- 0796US9957323B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted May 1, 2018·27 cites·26 claims
- 0896US9868790B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·29 claims
- 0996US9868789B2Synergistic combinations of OX40L antibodies for the treatment of GvHDKYMAB LTD·Filed 2017·Granted Jan 16, 2018·11 cites·19 claims
- 1094US11396550B2Methods of treating comprising administering anti-OX40L antibodiesKYMAB LTD·Filed 2017·Granted Jul 26, 2022·4 cites·54 claims
- 1194US10654935B2Methods of treating SLE with anti-OX40L antibodiesKYMAB LTD·Filed 2016·Granted May 19, 2020·7 cites·13 claims
- 1294US9587030B2Anti-hOX40L antibodies, uses, and methodsKYMAB LTD·Filed 2016·Granted Mar 7, 2017·14 cites·21 claims
- 1393US10669342B2Anti-OX40L antibodies and methods of treating graft versus host diseaseKYMAB LTD·Filed 2015·Granted Jun 2, 2020·7 cites·14 claims
- 1493US9434785B1Anti-human OX40L antibodies and methods of treating graft versus host disease with the sameKYMAB LTD·Filed 2015·Granted Sep 6, 2016·16 cites·30 claims
- 1593US8741604B2Nucleic acid molecule encoding a specific IL-1R1 antibodyCAMPBELL JAMIE IAIN·Filed 2012·Granted Jun 3, 2014·35 cites·6 claims
- 1691US11773175B2Antibodies, uses and methodsKYMAB LTD·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1789US11214620B2Binding molecules binding PD-L1 and LAG-3F STAR DELTA LTD·Filed 2017·Granted Jan 4, 2022·11 cites·20 claims
- 1888US2024132605A1Antibodies, uses & methodsKYMAB LTD·Filed 2023·Application pending·0 cites
- 1986US11629189B2Bispecific antibody for ICOS and PD-L1KYMAB LTD·Filed 2018·Granted Apr 18, 2023·4 cites·27 claims
- 2085US11858996B2Anti-ICOS antibodiesKYMAB LTD·Filed 2017·Granted Jan 2, 2024·2 cites·29 claims
- 2183US2024343810A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2024·Application pending·0 cites
- 2282US9200074B2Antibodies to IL-1 R1 and methods of making themMEDIMMUNE LTD·Filed 2014·Granted Dec 1, 2015·4 cites·22 claims
- 2381US2024158502A1Anti-icos antibodiesKYMAB LTD·Filed 2023·Application pending·0 cites
- 2479US10259880B2Anti-LIGHT antibodiesKYMAB LTD·Filed 2015·Granted Apr 16, 2019·3 cites·30 claims
- 2579US2025263492A1Antibodies, uses & methodsKYMAB LTD·Filed 2025·Application pending·0 cites
- 2678US11753479B2Nucleic acids encoding anti-OX40L antibodiesKYMAB LTD·Filed 2020·Granted Sep 12, 2023·0 cites·21 claims
- 2777US2022380467A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 2877US2022403029A1Anti-icos antibodiesKYMAB LTD·Filed 2022·Application pending·0 cites
- 2977US2023312720A1Multispecific antibodies for immuno-oncologyKYMAB LTD·Filed 2022·Application pending·0 cites
- 3076US8298533B2Antibodies to IL-1R1CAMPBELL JAMIE IAIN·Filed 2009·Granted Oct 30, 2012·2 cites·7 claims
- 3169US2019276547A1Antibodies, uses & methodsKYMAB LTD·Filed 2018·Application pending·0 cites
- 3268US2023348601A1Bispecific antibody for icos and pd-l1KYMAB LTD·Filed 2023·Application pending·0 cites
- 3361US2022372153A1Synergistic combinations of ox40l antibodies for the treatment of gvhdKYMAB LTD·Filed 2022·Application pending·0 cites
- 3461US2022185894A1Binding molecules binding pd-l1 and lag-3F STAR THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3560US2017037137A1Synergistic combinations of ox40l antibodies for the treatment of gvhdKYMAB LTD·Filed 2016·Application pending·0 cites
- 3656US2020190191A1Multispecific antibody with combination therapy for immuno-oncologyKYMAB LTD·Filed 2017·Application pending·0 cites
- 3752US2016096895A1Binding members-513MEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 3845US2017320956A1Anti-light antibodiesKYMAB LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jamie Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →